- Home
- USPH vs OCUL Comparison
USPH vs OCUL Comparison
Compare USPH & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USPH
- OCUL
- Stock Information
- Founded
- USPH 1990
- OCUL 2006
- Country
- USPH United States
- OCUL United States
- Employees
- USPH N/A
- OCUL N/A
- Industry
- USPH Medical/Nursing Services
- OCUL Biotechnology: Pharmaceutical Preparations
- Sector
- USPH Health Care
- OCUL Health Care
- Exchange
- USPH Nasdaq
- OCUL Nasdaq
- Market Cap
- USPH 1.1B
- OCUL 957.3M
- IPO Year
- USPH 1992
- OCUL 2014
- Fundamental
- Price
- USPH $70.98
- OCUL $7.45
- Analyst Decision
- USPH Strong Buy
- OCUL Strong Buy
- Analyst Count
- USPH 4
- OCUL 10
- Target Price
- USPH $109.00
- OCUL $16.11
- AVG Volume (30 Days)
- USPH 111.1K
- OCUL 1.6M
- Earning Date
- USPH 05-07-2025
- OCUL 05-05-2025
- Dividend Yield
- USPH 2.60%
- OCUL N/A
- EPS Growth
- USPH 63.40
- OCUL N/A
- EPS
- USPH 1.96
- OCUL N/A
- Revenue
- USPH $692,325,000.00
- OCUL $59,647,000.00
- Revenue This Year
- USPH $15.34
- OCUL $13.32
- Revenue Next Year
- USPH $5.91
- OCUL $13.13
- P/E Ratio
- USPH $36.21
- OCUL N/A
- Revenue Growth
- USPH 14.30
- OCUL N/A
- 52 Week Low
- USPH $62.77
- OCUL $4.06
- 52 Week High
- USPH $108.14
- OCUL $11.78
- Technical
- Relative Strength Index (RSI)
- USPH 48.44
- OCUL 48.17
- Support Level
- USPH $68.63
- OCUL $8.07
- Resistance Level
- USPH $75.11
- OCUL $8.90
- Average True Range (ATR)
- USPH 2.81
- OCUL 0.48
- MACD
- USPH 0.51
- OCUL -0.08
- Stochastic Oscillator
- USPH 59.14
- OCUL 29.68
About USPH U.S. Physical Therapy Inc.
US Physical Therapy Inc through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.